Citation only
via OpenAlex
Metabolic Signature Shift in Type 2 Diabetes Mellitus Revealed by Mass Spectrometry-based Metabolomics
Fengguo Xu, Tavintharan Subramaniam, Chee Fang Sum, Kaing Woon, Su Chi Lim, Choon Nam Ong
The Journal of Clinical Endocrinology & Metabolism · 2013 · ▲ 236 citations
Abstract
OBJECTIVE: Metabolic profiling of small molecules offers a snapshot of physiological processes. To identify metabolic signatures associated with type 2 diabetes and impaired fasting glucose (IFG) beyond differences in glucose, we used mass spectrometry-based metabolic profiling. RESEARCH DESIGN AND METHODS: Individuals attending an institutional health screen were enrolled. IFG (n = 24) was defined as fasting glucose (FG) of 6.1 to 6.9 mmol/L and 2-hour post glucose load <11.1 mmol/L or glycosylated hemoglobin <6.5%, type 2 diabetes (n = 27), FG ≥7.0 mmol/L, or 2-hour post glucose load ≥11.1 mmol/L, or glycosylated hemoglobin ≥6.5%, and healthy controls (n = 60), FG <6.1 mmol/L. Fasting serum metabolomes were profiled and compared using gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry. RESULTS: Compared to healthy controls, those with IFG and type 2 diabetes had significantly raised fructose, α-hydroxybutyrate, alanine, proline, phenylalanine, glutamine, branched-chain amino acids (leucine, isoleucine, and valine), low carbon number lipids (myristic, palmitic, and stearic acid), and significantly reduced pyroglutamic acid, glycerophospohlipids, and sphingomyelins, even after adjusting for age, gender, and body mass index. CONCLUSIONS: Using 2 highly sensitive metabolomic techniques, we report distinct serum profile change of a wide range of metabolites from healthy persons to type 2 diabetes mellitus. Apart from glucose, IFG and diabetes mellitus are characterized by abnormalities in amino acid, fatty acids, glycerophospholipids, and sphingomyelin metabolism. These early broad-spectrum metabolic changes emphasize the complex abnormalities present in a disease defined mainly by elevated blood glucose levels.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1210/jc.2012-4132
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Xu, F., Subramaniam, T., Sum, C.F., Woon, K., Lim, S.C., & Ong, C.N. (2013). Metabolic Signature Shift in Type 2 Diabetes Mellitus Revealed by Mass Spectrometry-based Metabolomics. <em>The Journal of Clinical Endocrinology & Metabolism</em>. https://doi.org/10.1210/jc.2012-4132
Vancouver
Xu F, Subramaniam T, Sum CF, Woon K, Lim SC, Ong CN. Metabolic Signature Shift in Type 2 Diabetes Mellitus Revealed by Mass Spectrometry-based Metabolomics. The Journal of Clinical Endocrinology & Metabolism. 2013. doi:10.1210/jc.2012-4132.
BibTeX
@article{fengguo2013Metabo,
title = {Metabolic Signature Shift in Type 2 Diabetes Mellitus Revealed by Mass Spectrometry-based Metabolomics},
author = {Fengguo Xu and Tavintharan Subramaniam and Chee Fang Sum and Kaing Woon and Su Chi Lim and Choon Nam Ong},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2013},
doi = {10.1210/jc.2012-4132},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2015
Open access · CC-BY
N-Glycomic Changes in Serum Proteins in Type 2 Diabetes Mellitus Correlate with Complications and with Metabolic Syndrome Parameters
Albert Einstein College of Medicine 2014
Open access · US-GOV
Metformin in Longevity Study (MILES).
Clinical Infectious Diseases 2018
Open access · OA
Metabolic Consequences of Concomitant Strongyloides stercoralis Infection in Patients With Type 2 Diabetes Mellitus
Diabetes and Vascular Disease Research 2012
Citation only
Metabolic syndrome defined by modified International Diabetes Federation criteria and type 2 diabetes mellitus risk: A 9-year follow-up among the aged in Finland
Molecular Metabolism 2017
Open access · CC-BY
Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis
Metabolic Syndrome and Related Disorders 2011
Preprint · OA